title: Comments on KDIGO clinical practice guidelines for bisphosphonate treatment of chronic kidney disease.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Przedlacki
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates